FindHealthNews Index  |  Save/Exchange Information |  WikiWax

    News, Reviews, and Articles on Vascular Diseases

    Archives: Vascular Diseases

    Dr. Andrew Zhu Joins Chemokine Therapeutics' Clinical Advisory Board  Aug 12, 2008
    VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 12, 2008) - Chemokine Therapeutics Corp. (the "Company") (TSX: - ; OTCBB: - ), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases, today announced that Dr. Andrew Zhu has joined the Company's Oncology Clinical Advisory Board. Comprised of leading oncologists, the Advisory Board plays an important role in guiding the CTCE-9908 clinical development program. (CCNMatthews Press Releases)

    ThromboGenics Announces Private Investors Acquire 8% Stake in the Company  Jul 30, 2008
    Desire Collen, Chairman and CEO of ThromboGenics, commenting on today's announcement, said: "We are very pleased that we have been able to attract such a group of high net worth individuals to become shareholders in ThromboGenics, particularly given their long term commitment to the Company. We are confident that we will be able to generate significant value for all our shareholders over the next several years based on the exciting prospects for microplasmin in the treatment of back of the eye... (PR Newswire)

    Cardiovascular Laboratory Receives Accreditation  Jul 25, 2008
    Early detection of these life-threatening vascular diseases is possible through the use of noninvasive vascular testing techniques performed within the vascular laboratories. Comprehensive Cardiovascular, P.C., located at 94-07 156th Ave., Howard Beach, is one of a select number of vascular laboratories in the United States, Canada and Puerto Rico to meet or exceed the ICAVL standards for noninvasive vascular testing. (Queens Chronicle, NY)

    AGA Medical Holdings Inc.  Jun 24, 2008
    which makes medical devices that treat structural heart and vascular diseases, has filed to go public. According to securities filings filed Friday, the IPO by the Golden Valley-based company could fetch as much as $200 million, though AGA said that price was used to calculate registration fees and could change. (Twin Cities Business Journal, MN)

    Complex Changes In The Brain's Vascular System Occur After Menopause  Jun 21, 2008
    After menopause, women are more likely to develop vascular diseases in the side streets or the tiny vessels. In these vessels, the symptoms are more subtle and harder to identify. (Science Daily)

    /R E P E A T -- The Montreal Heart Institute presents the findings of an international research project on congestive heart failure and atrial fibrillation/  Jun 19, 2008
    Its primary focus areas of research are vascular diseases, myocardial function and cardiac electrophysiology. MHI researchers also contribute to the advancement of knowledge and medical applications in the fields of genomics (in particular in disease gene discovery and pharmacogenomics), biomarkers and preventive cardiology. (Canada Newswire)

    New study offers hope to India's diabetes patients  Jun 14, 2008
    5 percent can reduce diabetes complications like kidney failure and cardiovascular diseases in a major way, shows a new study conducted across 20 countries including India. The ADVANCE (Action in Diabetes and Vascular Diseases) study - carried out by the George Institute, Australia, with its findings released in the US Saturday - has said that with diabetes becoming a global epidemic the risk of both economic and human loss will be huge ... This will save people from kidney damage or... (Sify)

    Patrick A. Cambier Named to First State Bank Board  Jun 13, 2008
    Dr. Cambier graduated from Hahnemann University School of Medicine in Philadelphia, PA. At Walter Reed Army Medical Center in Washington, DC, Major Cambier completed his residency in internal medicine, and fellowship training in interventional coronary and peripheral vascular diseases ... He is board certified in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology. (Primezone Releases)

    Chemokine Therapeutics Announces Final Results of CTCE-9908 Phase I/II Clinical Trial in Late Stage Cancer Patients  Jun 12, 2008
    VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 12, 2008) - Chemokine Therapeutics Corp. (the "Company") (TSX: - ; OTCBB: - ), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, today announced positive data following the successful completion of the Phase I/II clinical trial for CTCE-9908, the Company's anti-cancer drug candidate. ADVERTISEMENT. (CCNMatthews Press Releases)

    Winter wheat disease can be managed  Jun 4, 2008
    Unlike many vascular diseases that produce toxins and various compounds that gum up the vascular system of a plant and then cause wilting, Cephalosporium actually grows in the vascular tissue. The leaf symptoms of Cephalosporium stripe can occur from jointing to heading. (Mattoon Journal-Gazette, IL)

    Medical Ventures' Shareholders Approve Acquisitions and Related Activities  Jun 4, 2008
    The company's products help doctors treat a wide range of health conditions, including vascular diseases and obesity. They include the Metricath arterial and in-stent measurement system, and PeriPatch(TM) surgical tissue and staple line reinforcement products. (CCNMatthews Press Releases)

    ThromboGenics and BioInvent Report Positive Phase I Results for Anti-PlGF Cancer Therapeutic TB-403  Jun 3, 2008
    About ThromboGenics ThromboGenics is a biotechnology company focused on discovery and development of biopharmaceuticals for the treatment of a range of vascular diseases. The Company has several programs in Phase II clinical development including microplasmin, which is being evaluated as a treatment for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases, including acute stroke. (PR Newswire)

    Chemokine Therapeutics Announces Issuance of Two New U.S. Patents  May 28, 2008
    VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 28, 2008) - Chemokine Therapeutics Corp. (the "Company") (TSX: - ; OTCBB: - ), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases, today announced that it has been granted two U.S. Patents (No's 7,354,899 and 7,368,425) ... Patent No. 7,368,425 entitled "Cyclic Peptides for Modulating Growth of Neo-Vessels and Their Use in Therapeutic Angiogenesis" is related to the use of chemokine... (CCNMatthews Press Releases)

    Women’s Committee plans health fair  May 22, 2008
    The Life Line Screening program, which includes non-invasive screenings for vascular diseases, will also be held from 9 a.m. to 4 p.m.. Screenings include carotid artery/stroke, abdominal aortic aneurysm, peripheral arterial disease, and osteoporosis. (Kewanee Star Courier, IL)

    Half of the workforce in Indian industries overweight  May 20, 2008
    The study recommends imparting health education for preventing Cardio Vascular Diseases (CVD) and assess the impact of health education on controlling these diseases. The surveillance started with a baseline survey of more than 35,000 employees and their family members in 10 different industries in India in the age group of 10-69 years and a detailed risk factor survey of 20,000 randomly-selected individuals. (Economic Times)

    Hospital adapts to state's aging population  May 10, 2008
    Endovascular neuroradiology is treatment of vascular diseases of the central nervous system and spine without using surgery. The new suite, which is equipped with a state-of-the-art neuroradiology system, takes detailed X-ray images that allow the physician to reconstruct the patient's anatomy in a three-dimensional view. (Anchorage Daily News)

    Much Of The Increased Risk Of Death From Smoking Reduced Within Several Years After Quitting  May 8, 2008
    "Significant trends were observed with increasing years since quitting for all major cause-specific outcomes. A more rapid decline in risk after quitting smoking compared with continuing to smoke was observed in the first 5 years for vascular diseases compared with other causes.". "Much of the reduction in the excess risk for these causes of death were realized within the first 5 years for coronary heart disease and cerebrovascular disease. Sixty-one percent of the full potential benefit of... (Science Daily)

    ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke  Apr 9, 2008
    LEUVEN, Belgium, April 9 /PRNewswire-FirstCall/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on vascular diseases, eye diseases and cancer, announces today that it has completed patient enrolment for its Phase II MITI IV study ... About ThromboGenics ThromboGenics is a biotechnology company focused on discovery and development of biopharmaceuticals for the treatment of a range of vascular diseases. (PR Newswire)

    India a diabetic capital of the world  Apr 8, 2008
    Lifestyle related diseases like obesity, diabetes, cardio vascular diseases are afflicting India. India is also facing the old world problems of malaria, dengue, chikungunya, and diarrhoea,'' said Anthony J McMichael, a health scientist associated with the Intergovernmental Panel on Climate Change (IPCC). (NDTV.com)

    Chemokine Therapeutics Announces 2007 Financial and Operating Results  Apr 7, 2008
    VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 7, 2008) - Chemokine Therapeutics Corp. (the "Company") (TSX: - ; OTCBB: - ), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, today announced the financial and operating results of the year ended December 31, 2007. ADVERTISEMENT. (CCNMatthews Press Releases)

    Tobacco claims 8 lakh lives in India every year  Apr 7, 2008
    It increases blood pressure, heart rate, hastens hardening of arteries causing heart attacks and vascular diseases. Some vascular diseases like TAO and Bergers disease never occur in nonsmokers and so is the case with. (Newindpress)

    UK Heart Checks Could Save 2000 Lives Each Year  Apr 5, 2008
    A national programme to identify vulnerability to vascular diseases will prevent up to 9,500 heart attacks and strokes every year and save 2,000 lives, has been announced by UK Health Secretary Alan Johnson. Collectively, vascular diseases - heart disease, stroke, diabetes and kidney disease - affect the lives of more than four million people and kill 170,000 every year ... "We are also determined to tackle the inequalities in health, and vascular diseases are the main cause. All too often,... (Wireless Healthcare)

    Health MoT for the over-40s 'will save 2000 lives a year'  Apr 3, 2008
    " The MoTs will check the risk people face of developing vascular diseases - those which affect the blood vessels, such as heart disease, strokes, diabetes and kidney disease. Scroll down for more... Read more... Together, they affect the lives of four million and kill 170,000 every year. The Department of Health said the screening programme, which will cost 250million a year, will also prevent 4,000 a year from developing diabetes and detect at least 25,000 cases of diabetes or kidney disease... (Daily Mail)

    ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)  Apr 1, 2008
    LEUVEN, Belgium, April 1 /PRNewswire-FirstCall/ -- - Trial Results Expected Mid-2008 ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on vascular diseases, eye diseases and cancer, today announces that it has completed patient enrolment for its Phase IIb MIVI III trial in the United States ... About ThromboGenics ThromboGenics is a biotechnology company focused on discovery and development of biopharmaceuticals for the treatment of a range of vascular diseases. (PR Newswire)

    Woman encourages people to be heart smart  Mar 16, 2008
    Karen Paul was aware of vascular diseases in her family. Her mother, who died from a heart attack at age 75, warned Paul of the family s history. (Conroe Courier, TX)

    Encysive Pharmaceuticals Announces Date Change for Reporting 2007 Year-End Financials  Feb 22, 2008
    Our research and development programs are predominantly focused on the treatment and prevention of interrelated diseases of the vascular endothelium and exploit our expertise in the area of the intravascular inflammatory process, referred to as the inflammatory cascade, and vascular diseases. To learn more about Encysive Pharmaceuticals please visit our web site. (Primezone Releases)

    Stemcell transplantion a new boon for patients  Feb 4, 2008
    Till date, multicentric study of stem cell application by the hospital in spinal cord injury, liver cerosis and peripheral vascular diseases has proven the safety in all and efficacy in select group of patients, who otherwise have not other option of treatment at the moment, he said. The contention of ASSI was not in good taste and casting aspiration on fellow doctors and surgeons was against medical ethics, Dr J K B C Parthiban, neurosurgeon, Kovai Medical Center and Hospital, who himself is a... (Hindu)

    Injuries might boost clot risk  Jan 26, 2008
    Lawrence estimates that the center performs 4,000 to 5,000 ultrasounds a year for patients with vascular diseases. Of particular concern, he says, is the study s questionnaire format, in which venous thrombosis patients and a control group were asked about their recollections of previous injuries. (Albany Democrat-Herald, OR)

    Stroke, bone screens on Thursday  Jan 16, 2008
    These non-invasive, inexpensive and painless ultrasound tests help people identify their risk for stroke, vascular diseases or osteoporosis early enough for their physician to begin preventive procedures. For more information regarding the screenings or to schedule an appointment, those interested can call (877) 237-1377 or visit. (Coos Bay-North Bend The World, OR)

    Lipoic acid could reduce atherosclerosis, weight gain  Jan 15, 2008
    reducing known risk factors for the development of atherosclerosis and other inflammatory vascular diseases in humans ... As a result, the authors concluded that lipoic acid may be a useful adjunct in the prevention and treatment of atherosclerotic vascular diseases. (EurekAlert!)

    Low cancer risk for those with Down syndrome  Jan 3, 2008
    The basic biological mechanism, which affects blood vessel function and growth, may also underlie other so-called vascular diseases such as atherosclerosis, Folkman said. Folkman and other researchers believe people with Down produce extra endostatin naturally, but also that other genes play an important role. (MSNBC -- Health)

    Cut down of fat intake, consume more vegetables  Dec 30, 2007
    She noted that the recent rise in non communicable diseases in the country has been as a result of the unhealthy lifestyle choices resulting in diseases such cardio vascular diseases, cancer, diabetes, obesity, mental illness and bone and muscular diseases, which are described as the greatest killers of the day. Ms Adjei said, to increase the quality of the Ghanaians diet during these festivities, fruits and vegetables should be increased in both quantity and quality to supply the vitamins,... (Ghana Web, Ghana)

    What AM I? AM Is A Regulator Of Vascular System Functionality  Dec 21, 2007
    25, 2007) Low-density lipoprotein, a transporter of cholesterol, may also contribute to vascular diseases by a previously unidentified mechanism, according to a new report. The study reveals a link between. (Science Daily)

    Small RNAs and Large DNA Viruses  Dec 20, 2007
    Moreover, CMV infection is a leading cause of birth defects and has been implicated in the acceleration of long-term vascular diseases such as atherosclerosis. Like infection with other herpesviruses, a primary CMV infection is followed by a lifelong persistent or latent state of the virus in the host. (New England Journal of Medicine)

    ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting  Dec 11, 2007
    Professor Peter Verhamme, Department of Vascular Diseases, University of Leuven, who presented the results at the ASH meeting, commented: "The results from the first Phase I study with TB-402 show that this novel human monoclonal antibody is safe and well-tolerated, an important first step in the development of this new anticoagulant drug. Of equal importance, the results clearly indicate that TB-402 has the long half-life we predicted and a stable long-acting anticoagulant effect based on... (PR Newswire)

    ED in Younger Men Usually Psychogenic  Dec 4, 2007
    We dont see much of vascular diseases, so more of the cases are a result of what is between the ears. You dont see a lot of erectile dysfunction in men under the age of 40. (Newsmax)

    Erectile Dysfunction in Young Men Often Psychological  Nov 27, 2007
    We don t see much of vascular diseases so more of the cases are a result of what is between the ears. You don t see a lot of erectile dysfunction in men under the age of 40. (Fox News)

    Arterial Vascular Disease Underdiagnosed, Undertreated In Older US Women  Nov 23, 2007
    (May 2, 2007) Migraines during pregnancy are strongly linked to vascular diseases, such as stroke and heart disease, according to new. (Jan. (Science Daily)

    Shareholder Class Action Filed Against Micrus Endovascular Corporation by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP  Nov 17, 2007
    Micrus develops, manufactures, and markets implantable and disposable medical devices used in the treatment of cerebral vascular diseases. More specifically, the Complaint alleges that the Company failed to disclose and misrepresented the following material adverse facts which were known to defendants or recklessly disregarded by them: (1) that the Company was experiencing increased competition and seasonal slowing, which led to slower sales in North America; (2) that the Company was... (PR Newswire)

    HEALTH NOTES / Memorable tips about forgetfulness  Nov 16, 2007
    A number of studies in recent years have suggested that vascular diseases heart disease and stroke may contribute to the development of AD, the severity of AD, or the development of multi-infarct dementia (also called vascular dementia). Don't smoke or abuse alcohol. (Cohasset Mariner, MA)

    Looking at Glaucoma as a Systemic Disease  Nov 12, 2007
    Studies have found that patients with exfoliative glaucoma have a higher incidence of several other diseases, including Alzheimer's and vascular diseases. "The same genetic variation that affects the eye is probably active in all these other tissues," says Dr. Ritch. (PR Newswire)

    5,000 Patients Treated With OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Now Enrolled in Real-Life Use Global Registry  Nov 9, 2007
    "Completing enrollment in this large registry is an important milestone in our clinical development," said Samuel Rasmussen, OrbusNeich's president and CEO. OrbusNeich designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. In addition to Genous OrbusNeich's products are stents, balloons and guiding catheters marketed under the names of Blazer(TM), R stent(TM), Sapphire(TM), Avita(TM), Avita HP(TM), SafeCut(TM), Lumina(TM) and Saffron. (PR Newswire)

    ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell  Nov 2, 2007
    Desire Collen, CEO and Chairman of ThromboGenics, commented: "Today's publication in the prestigious journal Cell clearly highlights our ground-breaking research in the field of angiogenesis. The data in the Cell paper shows the potential of our novel anti-PlGF antibody, TB-403, based on its unique ability to block the development of new blood vessels, but only via mechanisms that exist in the diseased state. This mode of action, which is different from and complementary to current anti-VEGF... (PR Newswire)

    * Results of mortality rate study surprise researchers  Nov 1, 2007
    89 times more likely to die because of vascular diseases and 1 ... 49 times more likely to die from vascular diseases. (Taipei Times, Taiwan -- World)

    Contribution of cholesterol transporter to vascular disease  Oct 26, 2007
    Low-density lipoprotein, a transporter of cholesterol, may also contribute to vascular diseases by a previously unidentified mechanism, according to a report published online this week in EMBO reports. Low-density lipoprotein (LDL), a transporter of cholesterol, may also contribute to vascular diseases by a previously unidentified mechanism, according to a report published online this week in EMBO reports ... Vascular diseases such as thrombosis, stroke and heart attacks are associated with this... (EurekAlert!)

    Erectile Dysfunction: A Harbinger of Heart Trouble  Oct 6, 2007
    And now a growing body of research ties erectile dysfunction to vascular diseases, such as coronary artery disease. "Erectile dysfunction is often caused by vascular disease," explained Dr. Ian Thompson, professor and chairman of the department of urology at the University of Texas Health Science Center at San Antonio. (U.S. News & World Report)

    Chemokine Therapeutics Completes Patient Recruitment of CTCE-9908 Phase I/II Clinical Trial  Oct 2, 2007
    VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 2, 2007) - Chemokine Therapeutics Corp. (the "Company") (TSX: - ; OTCBB: - ), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, announced today that the Company has completed recruitment of its Phase I/II clinical study using its lead compound CTCE-9908 with late stage cancer patients. Dosing is expected to be completed by the end of October 2007 with results reported by the end of... (CCNMatthews Press Releases)

    Promising New Source Of Stem Cells: Mouse Testes Produce Wide Range Of Tissue Types  Sep 25, 2007
    If the same can be done with human cells, they say, adult stem cells may be a promising source of new therapies for men, for diseases such as vascular diseases, heart disease, Alzheimer's, Parkinson's, stroke, diabetes, and even cancer. Scientists have had good success in deriving pluripotent stem cell lines -- those with the ability to develop into multiple cell types -- from adult testes cells. (Science Daily)

    Stem Cells from Testes Produce Wide Range of Tissue Types  Sep 21, 2007
    If the same can be done with adult testes stem cells from humans, they may offer a source of new therapies to treat men with health problems such as heart disease, vascular diseases, diabetes, stroke, Parkinson's, Alzheimer's, and even cancer, the researchers said. The study, by Howard Hughes Medical Institute scientists, is published in the Sept. 20 issue of the journal Nature. (MEDLINEplus)

    Edwards Lifesciences gift to establish cardiovascular device research UCI, Sep. 12  Sep 13, 2007
    The Edwards Lifesciences Center for Advanced Cardiovascular Technology will promote interaction and collaboration among students, faculty members and experts by incorporating both undergraduate and graduate programs related to heart and vascular diseases. The programs will be directed by UCI's Department of Biomedical Engineering, and will involve a variety of other disciplines, including students from the Integrated Nanosystems Research Facility, the California Institute for Telecommunications... (University of California Newswire, CA)

    Rising early may be bad for the heart  Sep 8, 2007
    "Rising early to go to work or exercise might not be beneficial to health, but rather a risk for vascular diseases," said an abstract of the study. Dr V Mohan Kumar, vice-president of the World Federation of Sleep Research and Sleep Medicine Societies, told TOI that an adult needs a minimum of 6-8 hours of sleep everyday. (India Times, India -- Health/Science)

    Early risers more likely to have heart problems  Sep 7, 2007
    "Rising early to go to work or exercise might not be beneficial to health, but rather a risk for vascular diseases," said the study. The study, conducted by researchers from several universities and hospitals in the western Japanese city of Kyoto, revealed a link between wake-up times and a person's cardiovascular condition. (Xinhuanet, China)

    Little Shasta Valley rancher honored  Sep 6, 2007
    He is involved in a project of investigating the variation and opportunities to genetically select cattle for beef products that are more healthful especially as it relates to potential vascular diseases such as heart attacks. His work in this area includes participating as a cooperating producer with his calves. (Mount Shasta News, CA)

    ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent  Sep 4, 2007
    THR-100 is a thrombolytic agent developed for the treatment of acute myocardial infarction (AMI or heart attack) and other vascular diseases, based on its ability to dissolve blood clots ... Desire Collen, CEO of ThromboGenics, commented on today's announcement: "We are pleased that ThromboGenics and Bharat Biotech have successfully completed the technology transfer needed for the production of THR-100. Transfer of biopharmaceutical production technology from one company to another, or from one... (PR Newswire)

    Dr. Robbert de Winter to Present Pros and Cons of Drug-Eluting Stents and the Benefits of Using an Alternative Pro-Healing Stent to European Cardiologists  Aug 30, 2007
    The best recent scientific developments and novel research will be presented to medical professionals who deal with cardiovascular diseases in the course of their professional activity. About OrbusNeich OrbusNeich designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. (PR Newswire)

    MRI scans: Diagnostic tool grows in popularity  Aug 29, 2007
    It is likewise very valuable for the diagnosis of cancer, heart and vascular diseases. Wikipedia says that unlike X-rays and CT scans, MRI does not expose patients to any damaging forms of radiation. (Jakarta Post, Indonesia -- Features)

    Q&A with Sandy Feather: Digging deep to protect healthy oak trees from infected ones  Aug 25, 2007
    Vascular diseases such as oak wilt are easily transmitted from infected trees to healthy ones through such shared tissue. If your neighbor's trees are within 50 feet of your trees, it is likely their roots have grafted together. (Pittsburgh Post-Gazette, PA)

    Endologix Completes Enrollment in Powerlink Trial with 34 Millimeter Diameter Infrarenal Cuff  Aug 21, 2007
    Endologix, Inc. develops and manufactures minimally invasive treatments for vascular diseases. Endologix's Powerlink System is an endoluminal stent graft (ELG) for treating abdominal aortic aneurysms (AAA). (BusinessWire)

    160 mln Chinese adults suffer from blood fat abnormality  Aug 14, 2007
    Cardiovascular diseases, the No. 1 killer for Chinese, causes about 3 million deaths in the country, or 40 percent of the annual deaths number, according to Zhao Dong, director of Beijing's municipal center for the control of heart, lung and vascular diseases. Abnormal blood lipid is one of the main factors causing cardiovascular problems, the expert said. (Xinhuanet, China)

    OrbusNeich Expands Global Sales and Marketing Team  Jul 30, 2007
    OrbusNeich designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. The company's product portfolio includes the Genous Bio-engineered R stent, an antibody-coated device that is the first ever stent to capture a patient's endothelial progenitor cells (EPCs) to accelerate the natural healing process following placement. (PR Newswire)

    Ev3 buys FoxHollow for $780M  Jul 25, 2007
    FoxHollow makes devices to treat arterial blockage, whereas ev3 makes devices to treat vascular diseases. The companies said that the combined company would have a market capitalization of approximately $1. (Twin Cities Business Journal, MN)

    Medical Device Companies Announce Merger  Jul 23, 2007
    Merger plans were announced Sunday by medical device companies based in Minnesota and California that develop and market minimally invasive devices to treat vascular diseases and disorders. Plymouth-based ev3 Inc. and FoxHollow Technologies Inc. of Redwood City, Calif. (WCCO.com, MN)

    Drinking may not be so bad, say scientists  Jul 11, 2007
    Both help in preventing strokes and vascular diseases such as heart disease, and both have been shown to increase cognitive function. Just to give a few examples. (ABC Online)

    BMH brings Dr. Yue to city  Jul 8, 2007
    His interest is not only with cardiac disease, but also peripheral vascular diseases, such as renal arteries, carotid arteries and leg circulation ... Additionally he is board certified in Internal Medicine and Cardiovascular Diseases and has contributed to a variety of prestigious publications since 1989. (DeRidder Beauregard Daily News, LA)

    Erectile Dysfunction  May 29, 2007
    Vascular diseases and diabetes and, in a few cases, hormonal level imbalance, are all examples of physical problems. Within the physical problem category we should also include obesity, alcohol, smoking, the effects of some recreational drugs and some medicines. (Suite101.com)

    Chemokine Therapeutics Amends License Agreement With UBC  May 24, 2007
    VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - May 24, 2007) - Chemokine Therapeutics Corp. ("Chemokine" or the "Company") (TSX: - ; OTCBB: - ), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, today announced that it has amended certain terms of its license agreement with The University of British Columbia ("UBC") dated September 22, 1999. Under the terms of the license agreement with UBC, Chemokine was required to meet... (CCNMatthews Press Releases)

    Urodynamix Cancels Proposed Share Consolidation  May 23, 2007
    The Company is currently developing NIRS applications for urological conditions in men and women, intra-abdominal hypertension and compartment syndrome, erectile dysfunction and vascular diseases. The Company's disruptive technology has the potential to affect the diagnosis and treatment of more than 200 million people worldwide. (CCNMatthews Press Releases)

    Ways to prevent memory loss  May 22, 2007
    Vascular diseases -- heart disease and stroke -- can contribute to the development and severity of dementia and Alzheimer's disease. Don't smoke or abuse alcohol: Smokers perform worse than nonsmokers in studies of memory and thinking skills. (Akron Beacon Journal, OH -- Living)

    OrbusNeich Receives CE Mark Approval for Blazer(TM) Cobalt Chromium Stent, Sapphire(TM) PTCA Dilatation Catheter, Lumina(TM) Guiding Catheter  May 21, 2007
    " OrbusNeich designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. The company's product portfolio includes the Genous(TM) Bio-engineered R stent, an antibody-coated device that is the first-ever stent to capture a patient's endothelial progenitor cells (EPCs) to accelerate the natural healing process following placement. Other products are stents, balloons and guiding catheters marketed under the names of Blazer, R stent(TM), Sapphire,... (PR Newswire)

    Lifewire: More praise for the Mediterranean model  May 19, 2007
    Its purpose is to evaluate a series of hypotheses about men's health relating nutritional factors to the incidence of serious illnesses, such as cancer, heart disease, and other vascular diseases. The all-male study was designed to complement the all-female Nurses' Health Study, which examines similar hypotheses. (Bend Weekly)

    Migraines During Pregnancy Linked To Stroke And Other Vascular Diseases  May 3, 2007
    Migraines during pregnancy are strongly linked to vascular diseases, such as stroke and heart disease, according to new research. Researchers looked at a national database of nearly 17 million women discharged for pregnancy deliveries from 2000-2003. (Science Daily)

    Ev3 to raise $166.25M in secondary offering  Apr 22, 2007
    Ev3 is a global medical device company focused on catheter-based technologies for the endovascular treatment of vascular diseases and disorders. cwyant@bizjournals. (Twin Cities Business Journal, MN)

    Chemokine Therapeutics announces 2006 financial and operating results  Apr 17, 2007
    TSX: CTI OTCBB: CHKT VANCOUVER, April 16 /PRNewswire-FirstCall/ - Chemokine Therapeutics Corp. (the "Company") (TSX:CTI, OTCBB:CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, today announced highlights and the financial and operating results of the year ended December 31, 2006. 2006 Highlights: - Commencement and continued enrollment of subjects to the Phase Ib/II clinical study of CTCE-9908 to assess the safety and... (PR Newswire)

    Scientists find major susceptibility genes for Crohn's disease  Apr 17, 2007
    Founded in 1954, the Montreal Heart Institute is Canada's largest and oldest institution dedicated to research, education and clinical care of cardiovascular diseases ... Its prime focus areas of research are vascular diseases, myocardial function and electrophysiology. (EurekAlert!)

    Thrombogenics Announces License Agreement With Millipore for Commercialization of Stem Cell Medium Technology  Apr 16, 2007
    About ThromboGenics ThromboGenics is a biotechnology company focused on discovery and development of biopharmaceuticals for the treatment of a range of vascular diseases. The Company has several programs in Phase II clinical development including microplasmin, which is being evaluated as a treatment for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases, including acute stroke. (PR Newswire)

    GO Capital Becomes Major Shareholder in ThromboGenics  Mar 27, 2007
    Desire Collen, CEO of ThromboGenics, said: "We are pleased that GO Capital, a highly regarded asset manager and experienced investor in the biotech space, has decided to acquire a significant position in ThromboGenics. This is an important vote of confidence in our product pipeline, our management team and our cutting edge science. We look forward to their long term support as we work to maximize the value of our late stage clinical pipeline, particularly microplasmin for the treatment of back... (PR Newswire)

    Lotus CEO Announces Expansion Strategy to Reach China's Top Tier of Pharmaceuticals With Revenues Exceeding $100 Million  Mar 21, 2007
    One of the new drugs, already in the clinical trial stage, is classified as a 'National Class One New Drug' for cardiac vascular diseases. This drug is expected to deliver an effective and cheap alternative to the current costly drugs of the same category. (Primezone Releases)

    Cholesterol dip linked to mental decline  Mar 18, 2007
    Kivipelto and colleagues believe that declining cholesterol after middle age may "reflect ongoing pathological processes in the brain." Nonetheless, they say the relationship between cholesterol and dementia is "controversial," and meanwhile, they point out, high cholesterol "carries risk even in old age, and results from clinical trials in vascular diseases support the benefit of lipid-lowering treatment in elderly patients.". SOURCE: Neurology, March 6, 2007. (Sydney Morning Herald -- World)

    THELIN (sitaxentan sodium) Receives Australian Marketing Approval  Mar 7, 2007
    Our research and development programs are predominantly focused on the treatment and prevention of interrelated diseases of the vascular endothelium and exploit our expertise in the area of the intravascular inflammatory process, referred to as the inflammatory cascade, and vascular diseases. To learn more about Encysive Pharmaceuticals please visit our web site. (Primezone Releases)

    Heart disease rate in the US on the rise  Feb 17, 2007
    Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. (Food Consumer)

    Lung transplant for Australian teenage girl  Feb 16, 2007
    This site contains information for professionals and the general public about heart and vascular diseases, lung diseases, blood diseases. - To build public awareness of lung cancer, four national cancer organizations are uniting to launch a nationwide lung cancer awareness campaign. (SpiritIndia)

    Life Line Screenings to be offered  Feb 15, 2007
    The non-invasive ultrasound tests help people identify their risk for stroke, vascular diseases or osteoporosis early enough for their physician to begin preventive procedures. The First Baptist Church is located at 13560 N. State Highway 5 in Sunrise Beach. (Camdenton Lake Sun Leader, MO)

    Poor people worse off following heart attack  Feb 14, 2007
    Patients in the lowest income quartile were more likely to be older, female and to have other illnesses such as diabetes and peripheral vascular diseases. Researchers first looked at who was more likely to have an angioplasty or coronary bypass surgery and then did a one-year follow-up after the emergency department visit to see whether the patient was still alive. (EurekAlert!)

    NOTCHing Up Heart Development  Feb 6, 2007
    In an accompanying commentary, Leonard Anderson and Gary Gibbons from the Morehouse School of Medicine, Atlanta, discuss the intriguing possibility that defects in the Notch signaling cascade might also be important in adult vascular diseases; something that Epstein and colleagues also suggest. Note: This story has been adapted from a news release issued by Journal of Clinical Investigation. (Science Daily)

    ThromboGenics Strengthens its Management Team  Feb 5, 2007
    Professor Desire Collen, CEO and Chairman of ThromboGenics, said: "I am delighted that we have been able to attract such a group of highly experienced industry professionals to ThromboGenics. I am confident that our strengthened management team will enable us to create further value for our shareholders by advancing the clinical programmes of our most promising drug candidates in back of the eye and vascular disease, and supporting the company in delivering our key corporate objectives." About... (PR Newswire)

    Archives: Vascular Diseases

    Back to FindHealthNews Home

[ Terms Of Use | Privacy | About ]
©1998-2006 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2006